Skip to main content
Isaac Francis Photo
Isaac Francis

Isaac Francis

GrafaFinance Journalist

Finance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.

Articles by Isaac Francis

Grafa

Precigen projects record Q1 revenue following permanent J-Code for PAPZIMEOS

Precigen (NASDAQ:PGEN), a biopharmaceutical company specializing in the development of gene and cell therapies, has announced a significant acceleration in the commercial rollout of PAPZIMEOS™ (zopapogene imadenovec-drba), projecting first-quarter 2026 revenue to exceed $18 million.

Read more: Precigen projects record Q1 revenue following permanent J-Code for PAPZIMEOS
Grafa

Greenwich LifeSciences files patent claims to double GP2 market opportunity

Greenwich LifeSciences (NASDAQ:GLSI), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences, has filed new patent claims that could significantly expand the addressable market for its lead candidate, GLSI-100.

Read more: Greenwich LifeSciences files patent claims to double GP2 market opportunity